Shiva Abolhasani

4 ta ish

Tabriz University of Medical Sciences

1. Targeted Silencing of NRF2 by rituximab-conjugated nanoparticles increases the sensitivity of chronic lymphoblastic leukemia cells to Cyclophosphamide

   Atefeh Khodakarami, Mahsa Afsari Kashani, Atefeh Nazer +13

   MaqolaOAOchiq kirish20235 iqtibos

   ABIABI:AkademIndex/2026.other.130704

2. The molecular biology and therapeutic potential of Nrf2 in leukemia

   Atefeh Khodakarami, Sara Adibfar, Vahid Karpisheh +6

   Sharh maqola20225 iqtibos

   ABIABI:AkademIndex/2026.other.456313

3. Advancing the therapeutic effectiveness of paclitaxel in chronic lymphocytic leukemia through the simultaneous inhibition of NOTCH1 and SF3B1

   Shiva Abolhasani, Armin Mahmoud Salehi Khesht, Atefeh Khodakarami +13

   Maqola20254 iqtibos

   ABIABI:AkademIndex/2026.other.826326

4. The role of <scp>SF3B1</scp> and <scp>NOTCH1</scp> in the pathogenesis of leukemia

   Shiva Abolhasani, Seyyed Sina Hejazian, Vahid Karpisheh +5

   Sharh maqola20224 iqtibos

   ABIABI:AkademIndex/2026.other.837954